NCT01092533 - Myfortic for the Treatment of Non-infectious Intermediate Uveitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Uveitis, Intermediate

Interventions

DRUG

Myfortic

Myfortic 360 mg BID (during week 1) Myfortic 720 mg BID (from week 2 on) Maintenance dose Decortin 5mg/d

DRUG

Decortin

Maintenance dose 5 mg/d

Trial Locations (5)

Charité Universitätsmedizin Berlin, Augenklinik, Berlin

Augenabteilung am St. Franziskus-Hospital Münster, Münster

Universitätsklinikum Heidelberg, Interdisziplinäres Uveitiszentrum, Heidelberg

Universitäts-Augenklinik Freiburg, Freiburg im Breisgau

Augenklinik der Ludwig-Maximilians-Universität München, München